3,0
6 set 2015
Dipendente anonimo
Dipendente attuale, più di 10 anni
South San Francisco, CA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
"Patients first" and "science driven" are not just slogans, they are meaningful and motivating.
Svantaggi
The ability to get things done has greatly eroded. Politics within and across functions have removed projects as the central focus. There are too many committees before decisions are made, which slows everything in the pipeline and portfolio. Leadership is average, used to be stellar. Is now an extremely risk averse environment, after Roche acquired Genentech. Benefits chiseled away every year. Even the price of food in cafeteria has risen - salmon, rice, carrots this week for lunch was over $10.